Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab + Timolol-Dorzolamide for Diabetic Macular Edema
NCT05083689Phase 3Unknown
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Oct 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of timolol maleate gel + placebo, dorzolamide in diabetic macular edema (DME), sponsored by Shahid Beheshti University of Medical Sciences. Status: unknown.
02
Drugs
timolol maleate gel + placebodorzolamide
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT05083689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05083689.